Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Lead negatively impacts cognitive functions of boys more than girls

  • 'July Effect' doesn?t apply to length of surgery

  • Early English exposure prepares Spanish-speaking children for academic success

  • Brain Secrets Unlocked by International Imaging Effort

  • Estrogen-producing neurons influence aggression in both sexes

  • Secrets of a clump-dissolving protein uncovered

  • Family voices, stories speed coma recovery

  • Prescription painkillers, widely used by childbearing age women, double birth defects risk

  • Low-income boys fare worse in wealth's shadow

  • Tablet computers good medium for educational materials

  •